FDA rejects MDMA for PTSD, delaying access to life-saving treatment though some states are introducing psychedelic therapy programs.

The Healing Advocacy Fund reported that over 3,500 clients received psilocybin-assisted therapy at Oregon’s first psilocybin service center in 2023. The cost of these treatments is typically much lower than what is projected for FDA-approved MDMA therapies.